| TAZ-TFG-2023-1535 |
Análisis de la sostenibilidad de once empresas farmacéuticas: Valoración del acceso a los medicamentos en los países de rentas bajas y medias (LMICs).
Bruna Cebrian, Miguel
Ripoll Campo, Lara (dir.)
Universidad de Zaragoza,
ECON,
2023
Contabilidad y Finanzas department, Economía Financiera y Contabilidad area
Graduado en Administración y Dirección de Empresas
Tipo de Trabajo Académico: Trabajo Fin de Grado
Notas: Resumen en inglés: This dissertation aims to create a framework that allows to analyse and compare the information that pharmaceutical companies provide in their integrated reports, annual reports, and websites. Attention will be paid to the measures of access to medicines that different companies offer especially targeted at low- and middle-income countries. The purpose of this research project is to create a ranking of the pharmaceutical companies that offer the greatest access measures in these countries, aiming to discover which ones are being implemented and which ones could be introduced in order to further ensure and improve access to medicines. Due to the relevance that Environmental Social Governance (ESG) criteria have acquired in recent times, there is a need to create a framework that allows us to compare the information that the different companies offer in order to make an analysis not only transversal (between different companies) but also longitudinal (over time).
Notas: Resumen en inglés: This dissertation aims to create a framework that allows to analyse and compare the information that pharmaceutical companies provide in their integrated reports, annual reports, and websites. Attention will be paid to the measures of access to medicines that different companies offer especially targeted at low- and middle-income countries. The purpose of this research project is to create a ranking of the pharmaceutical companies that offer the greatest access measures in these countries, aiming to discover which ones are being implemented and which ones could be introduced in order to further ensure and improve access to medicines. Due to the relevance that Environmental Social Governance (ESG) criteria have acquired in recent times, there is a need to create a framework that allows us to compare the information that the different companies offer in order to make an analysis not only transversal (between different companies) but also longitudinal (over time).
Permalink:
El registro pertenece a las siguientes colecciones:
trabajos-academicos-universidad-zaragoza > centro > facultad-de-economia-y-empresa
trabajos-academicos-universidad-zaragoza > trabajos-fin-grado